Anti-arthritis effects of vitamin K2 (menaquinone-4) - A new potential therapeutic strategy for rheumatoid arthritis

FEBS Journal

Volumn 274, Issue 17, 2007, Pages 4588-4594

  Okamoto, Hiroshi ^a   Shidara, Kumi ^a   Hoshi, Daisuke ^a   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Collagen type II induced arthritis; Rheumatoid arthritis; Vitamin K2 (menaquinone 4)

Indexed keywords

3 (4,5 DEMETHYLTHIAZOL METHYLTHIAZOL 2 YL) 2,5 DIPHENYLTETRAZOLIUM; BROMIDE; CASPASE 3; CASPASE 7; COLLAGEN; DNA FRAGMENT; LIPOCORTIN 5; MENATETRENONE; TETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DARK AGOUTI RAT; DOSE RESPONSE; DRUG EFFECT; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ADMINISTRATION, ORAL; ANIMALS; APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; FEMALE; RATS; VITAMIN K 2;

AGOUTI; RATTUS;

EID: 34548136102     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.05987.x     Document Type: Article

References (27)

1. Suttie JW (1993) Synthesis of vitamin K-dependent proteins. FASEB J 7, 445 452.
2. Liu Y, Nelson AN Lipsky JJ (1996) Vitamin K-dependent carboxylase: mRNA distribution and effects of vitamin K-deficiency and warfarin treatment. Biochem Biophys Res Commun 224, 549 554.
3. Simon RR, Beaudin SM, Johnston M, Walton KJ Shaughnessy SG (2002) Long-term treatment with sodium warfarin results in decreased femoral bone strength and cancellous bone volume in rats. Thromb Res 105, 353 358.
4. Yamaguchi M, Taguchi H, Gao YH, Igarashi A Tsukamoto Y (1999) Effect of vitamin K2 (menaquinone-7) in fermented soybean (natto) on bone loss in ovariectomized rats. J Bone Miner Metab 17, 23 29.
5. Akiyama Y, Hara K, Tajima T, Murota S Morita I (1994) Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures. Eur J Pharmacol 263, 181 185.
6. Kameda T, Miyazawa K, Mori Y, Yuasa T, Shiokawa M, Nakamaru Y, Mano H, Hakeda Y, Kameda A Kumegawa M (1996) Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun 220, 515 519.
7. Shiraki M, Shiraki Y, Aoki C Miura M (2000) Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 15, 515 521.
8. Wang Z, Wang M, Finn F Carr BI (1995) The growth inhibitory effect of vitamins K and their actions on gene expression. Hepatology 2, 875 882.
9. Yaguchi M, Miyazawa K, Katagiri T, Nishimaki J, Kizaki M, Tohyama K Toyama K (1997) Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid. Leukemia 11, 779 787.
10. Yaguchi M, Miyazawa M, Otawa M, Katagiri T, Nishimaki J, Uchida Y, Iwase O, Gotoh A, Kawanishi Y Toyama K (1998) Vitamin K2 selectively induces apoptosis of blastic cells in myelodysplastic syndrome: flow cytometric detection of apoptotic cells using APO2.7 monoclonal antibody. Leukemia 12, 1392 1397.
11. Miyazawa K, Nishimaki J, Ohyashiki K, Enomoto S, Kuriya S, Fukuda R, Hotta T, Teramura M, Mizoguchi H, Uchiyama T et al. (2000) Vitamin K2 therapy for myelodysplastic syndrome (MDS) and post-MDS acute myeloid leukemia: information through a questionnaire survey of multi-center pilot studies in Japan. Leukemia 14, 1156 1157.
12. Takami A, Nakao S, Ontachi Y, Yamauchi H Matsuda T (1998) Successful therapy of myelodysplastic syndrome with menatetrenone, a vitamin K2 analog. Int J Hematol 69, 24 26.
13. Fujita H, Tomiyama J Tanaka T (1998) Vitamin K2 combined with all-trans retinoic acid induced complete remission of relapsing acute promyelocytic leukemia. Br J Haematol 103, 584 585.
14. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423, 356 361.
15. Franz JK, Pap T, Hummel KM, Nawrath M, Aicher WK, Shigeyama Y, Muller-Ladner U, Gay RE Gay S (2000) Expression of sentrin, a novel anti-apoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum 43, 599 607.
16. Perlman H, Liu H, Georganas C, Koch AE, Shamiyeh E, Haines GK 3rd & Pope RM (2001) Differential expression pattern of the anti-apoptotic proteins, Bcl-2 and FLIP, in experimental arthritis. Arthritis Rheum 44, 2899 2908.
17. Schedel J, Gay RE, Kuenzler P, Seemayer C, Simmen B, Michel BA Gay S (2002) FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis. Arthritis Rheum 46, 1512 1518.
18. Catrina AI, Ulfgren AK, Lindblad S, Grondal L Klareskog L (2002) Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium. Ann Rheum Dis 61, 934 936.
19. Goberdhan DC Wilson C (2003) PTEN: tumour suppressor, multifunctional growth regulator and more. Hum Mol Genet 12, R239 R248.
20. Pap T, Franz JK, Hummel KM, Jeisy E, Gay R Gay S (2000) Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res 2, 59 64.
21. Kim WU, Yoo SA, Min SY, Park SH, Koh HS, Song SW Cho CS (2006) Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes. Clin Exp Immunol 144, 503 511.
22. Wunder A, Schellenberger E, Mahmood U, Bogdanov A Jr., Muller-Ladner U, Weissleder R Josephson L (2005) Methotrexate-induced accumulation of fluorescent annexin V in collagen-induced arthritis. Mol Imaging 4, 1 6.
23. Nakazawa F, Matsuno H, Yudoh K, Katayama R, Sawai T, Uzuki M Kimura T (2001) Methotrexate inhibits rheumatoid synovitis by inducing apoptosis. J Rheumatol 28, 1800 1808.
24. Sawada T, Hashimoto S, Furukawa H, Tohma S, Inoue T Ito K (1997) Generation of reactive oxygen species is required for bucillamine, a novel anti-rheumatic drug, to induce apoptosis in concert with copper. Immunopharmacology 35, 195 202.
25. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al. (1987) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315 324.
26. Okamoto H, Cujec TP, Okamoto M, Peterlin BM, Baba M Okamoto T (2000) Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37. Virology 272, 402 408.
27. Larsson E, Harris HE, Palmblad K, Mansson B, Saxne T Klareskog L (2005) CNI-1493, an inhibitor of pro-inflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis. Ann Rheum Dis 64, 494 496.